OPKO Health Files 8-K on Financials
Ticker: OPK · Form: 8-K · Filed: Oct 29, 2025 · CIK: 944809
| Field | Detail |
|---|---|
| Company | Opko Health, INC. (OPK) |
| Form Type | 8-K |
| Filed Date | Oct 29, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
OPKO Health dropped an 8-K on Oct 29, 2025, detailing financial condition and results. Check it out.
AI Summary
On October 29, 2025, OPKO Health, Inc. filed an 8-K report. The filing indicates a change in the company's financial condition and results of operations. It also includes financial statements and exhibits related to these changes.
Why It Matters
This 8-K filing provides crucial updates on OPKO Health's financial performance and condition, which could impact investor decisions.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price, necessitating careful review.
Key Players & Entities
- OPKO Health, Inc. (company) — Registrant
- October 29, 2025 (date) — Date of earliest event reported
- 305-575-4181 (phone_number) — Business phone number
- Miami, Florida (location) — Principal executive offices location
FAQ
What specific event triggered this 8-K filing?
The filing indicates changes in 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', suggesting a material event impacting the company's financial status.
When was the earliest event reported in this filing?
The earliest event reported was on October 29, 2025.
What is OPKO Health, Inc.'s primary business classification?
OPKO Health, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where are OPKO Health, Inc.'s principal executive offices located?
The principal executive offices are located at 4400 Biscayne Blvd., Miami, Florida 33137.
What is the SEC file number for OPKO Health, Inc.?
The SEC file number for OPKO Health, Inc. is 001-33528.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-10-29 16:11:05
Filing Documents
- opk-20251029.htm (8-K) — 50KB
- opk-ex99_1.htm (EX-99.1) — 289KB
- img172623995_0.jpg (GRAPHIC) — 12KB
- 0001193125-25-256325.txt ( ) — 473KB
- opk-20251029.xsd (EX-101.SCH) — 23KB
- opk-20251029_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On October 29, 2025, OPKO Health, Inc. (the "Company") issued a press release announcing operating and financial highlights for the quarter ended September 30, 2025. The press release also contains information on how to access the conference call the Company is hosting to provide a business update and discuss its financial and operating results for the third quarter ended September 30, 2025, as well as provide financial guidance. A copy of the press release is attached hereto as Exhibit 99.1. The information included herein and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of the Company dated October 29, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OPKO Health, Inc. By: /s/ Adam Logal Date: October 29, 2025 Name: Adam Logal Title: Senior Vice President, Chief Financial Officer